Literature DB >> 25182515

Molecular pathways: the PERKs and pitfalls of targeting the unfolded protein response in cancer.

Nancy L Maas1, J Alan Diehl2.   

Abstract

The endoplasmic reticulum (ER) is a highly specialized organelle that provides an oxidizing, profolding environment for protein synthesis and maturation. The ER also hosts a dynamic signaling network that can sense and respond to physiologic changes that affect its environment, thereby influencing overall cell fate. Limitation of nutrients and oxygen have a direct effect on the efficiency of protein folding in the ER, and are classic inducers of the ER resident signaling pathway, the unfolded protein response (UPR). Not only does the UPR regulate ER homeostasis in normal cells experiencing such stress, but strong evidence also suggests that tumor cells can co-opt the cytoprotective aspects of this response to survive the hypoxic, nutrient-restricted conditions of the tumor microenvironment. ©2014 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2014        PMID: 25182515      PMCID: PMC4334714          DOI: 10.1158/1078-0432.CCR-13-3239

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  55 in total

1.  Dynamic interaction of BiP and ER stress transducers in the unfolded-protein response.

Authors:  A Bertolotti; Y Zhang; L M Hendershot; H P Harding; D Ron
Journal:  Nat Cell Biol       Date:  2000-06       Impact factor: 28.824

2.  ER stress is associated with dedifferentiation and an epithelial-to-mesenchymal transition-like phenotype in PC Cl3 thyroid cells.

Authors:  Luca Ulianich; Corrado Garbi; Antonella Sonia Treglia; Dario Punzi; Claudia Miele; Gregory Alexander Raciti; Francesco Beguinot; Eduardo Consiglio; Bruno Di Jeso
Journal:  J Cell Sci       Date:  2008-01-22       Impact factor: 5.285

3.  ER stress-regulated translation increases tolerance to extreme hypoxia and promotes tumor growth.

Authors:  Meixia Bi; Christine Naczki; Marianne Koritzinsky; Diane Fels; Jaime Blais; Nianping Hu; Heather Harding; Isabelle Novoa; Mahesh Varia; James Raleigh; Donalyn Scheuner; Randal J Kaufman; John Bell; David Ron; Bradly G Wouters; Constantinos Koumenis
Journal:  EMBO J       Date:  2005-09-08       Impact factor: 11.598

4.  Decay of endoplasmic reticulum-localized mRNAs during the unfolded protein response.

Authors:  Julie Hollien; Jonathan S Weissman
Journal:  Science       Date:  2006-07-07       Impact factor: 47.728

5.  An integrated stress response regulates amino acid metabolism and resistance to oxidative stress.

Authors:  Heather P Harding; Yuhong Zhang; Huiquing Zeng; Isabel Novoa; Phoebe D Lu; Marcella Calfon; Navid Sadri; Chi Yun; Brian Popko; Richard Paules; David F Stojdl; John C Bell; Thore Hettmann; Jeffrey M Leiden; David Ron
Journal:  Mol Cell       Date:  2003-03       Impact factor: 17.970

6.  Overexpression of the glucose-regulated stress gene GRP78 in malignant but not benign human breast lesions.

Authors:  P M Fernandez; S O Tabbara; L K Jacobs; F C Manning; T N Tsangaris; A M Schwartz; K A Kennedy; S R Patierno
Journal:  Breast Cancer Res Treat       Date:  2000-01       Impact factor: 4.872

7.  Activation of the ATF6, XBP1 and grp78 genes in human hepatocellular carcinoma: a possible involvement of the ER stress pathway in hepatocarcinogenesis.

Authors:  Masahiro Shuda; Nobuo Kondoh; Nobuo Imazeki; Kenji Tanaka; Tetsuya Okada; Kazutoshi Mori; Akiyuki Hada; Masaaki Arai; Toru Wakatsuki; Osamu Matsubara; Naoki Yamamoto; Mikio Yamamoto
Journal:  J Hepatol       Date:  2003-05       Impact factor: 25.083

8.  Dual function of pancreatic endoplasmic reticulum kinase in tumor cell growth arrest and survival.

Authors:  Aparna C Ranganathan; Shishir Ojha; Antonis Kourtidis; Douglas S Conklin; Julio A Aguirre-Ghiso
Journal:  Cancer Res       Date:  2008-05-01       Impact factor: 12.701

9.  (-)-Epigallocatechin gallate sensitizes breast cancer cells to paclitaxel in a murine model of breast carcinoma.

Authors:  Ting Luo; Jiao Wang; Yancun Yin; Hui Hua; Jing Jing; Xiangming Sun; Minjing Li; You Zhang; Yangfu Jiang
Journal:  Breast Cancer Res       Date:  2010-01-15       Impact factor: 6.466

10.  Abrogation of translation initiation factor eIF-2 phosphorylation causes malignant transformation of NIH 3T3 cells.

Authors:  O Donzé; R Jagus; A E Koromilas; J W Hershey; N Sonenberg
Journal:  EMBO J       Date:  1995-08-01       Impact factor: 11.598

View more
  17 in total

1.  Getting the better of ER stress.

Authors:  Bertrand Mollereau; Serge Manié; Francesco Napoletano
Journal:  J Cell Commun Signal       Date:  2014-10-30       Impact factor: 5.782

2.  Klotho suppresses colorectal cancer through modulation of the unfolded protein response.

Authors:  Tammi Arbel Rubinstein; Shiri Shahmoon; Ehud Zigmond; Tal Etan; Keren Merenbakh-Lamin; Metsada Pasmanik-Chor; Gil Har-Zahav; Iris Barshack; Gilad W Vainer; Nir Skalka; Rina Rosin-Arbesfeld; Chen Varol; Tami Rubinek; Ido Wolf
Journal:  Oncogene       Date:  2018-09-19       Impact factor: 9.867

Review 3.  Endoplasmic reticulum-mediated unfolded protein response and mitochondrial apoptosis in cancer.

Authors:  Tariq A Bhat; Ajay K Chaudhary; Sandeep Kumar; Jordan O'Malley; Joseph R Inigo; Rahul Kumar; Neelu Yadav; Dhyan Chandra
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2016-12-15       Impact factor: 10.680

4.  The Unfolded Protein Response Mediator PERK Governs Myeloid Cell-Driven Immunosuppression in Tumors through Inhibition of STING Signaling.

Authors:  Eslam Mohamed; Rosa A Sierra; Jimena Trillo-Tinoco; Yu Cao; Patrick Innamarato; Kyle K Payne; Alvaro de Mingo Pulido; Jessica Mandula; Shuzhong Zhang; Paul Thevenot; Subir Biswas; Sarah K Abdalla; Tara Lee Costich; Kay Hänggi; Carmen M Anadon; Elsa R Flores; Eric B Haura; Shikhar Mehrotra; Shari Pilon-Thomas; Brian Ruffell; David H Munn; Juan R Cubillos-Ruiz; Jose R Conejo-Garcia; Paulo C Rodriguez
Journal:  Immunity       Date:  2020-04-14       Impact factor: 31.745

5.  Codon misreading tRNAs promote tumor growth in mice.

Authors:  Mafalda Santos; Patricia M Pereira; A Sofia Varanda; Joana Carvalho; Mafalda Azevedo; Denisa D Mateus; Nuno Mendes; Patricia Oliveira; Fábio Trindade; Marta Teixeira Pinto; Renata Bordeira-Carriço; Fátima Carneiro; Rui Vitorino; Carla Oliveira; Manuel A S Santos
Journal:  RNA Biol       Date:  2018-06-07       Impact factor: 4.652

6.  QRICH1 dictates the outcome of ER stress through transcriptional control of proteostasis.

Authors:  Kwontae You; Lingfei Wang; Chih-Hung Chou; Kai Liu; Toru Nakata; Alok Jaiswal; Junmei Yao; Ariel Lefkovith; Abdifatah Omar; Jacqueline G Perrigoue; Jennifer E Towne; Aviv Regev; Daniel B Graham; Ramnik J Xavier
Journal:  Science       Date:  2021-01-01       Impact factor: 47.728

7.  Development and Validation of an Inflammatory Response-Related Gene Signature for Predicting the Prognosis of Pancreatic Adenocarcinoma.

Authors:  Zu-Liang Deng; Ding-Zhong Zhou; Su-Juan Cao; Qing Li; Jian-Fang Zhang; Hui Xie
Journal:  Inflammation       Date:  2022-03-23       Impact factor: 4.092

Review 8.  Unfolding anti-tumor immunity: ER stress responses sculpt tolerogenic myeloid cells in cancer.

Authors:  Juan R Cubillos-Ruiz; Eslam Mohamed; Paulo C Rodriguez
Journal:  J Immunother Cancer       Date:  2017-01-17       Impact factor: 13.751

9.  Activating transcription factor 3 promotes loss of the acinar cell phenotype in response to cerulein-induced pancreatitis in mice.

Authors:  Elena N Fazio; Claire C Young; Jelena Toma; Michael Levy; Kurt R Berger; Charis L Johnson; Rashid Mehmood; Patrick Swan; Alphonse Chu; Sean P Cregan; F Jeffrey Dilworth; Christopher J Howlett; Christopher L Pin
Journal:  Mol Biol Cell       Date:  2017-07-12       Impact factor: 4.138

10.  mTOR inhibitors activate PERK signaling and favor viability of gastrointestinal neuroendocrine cell lines.

Authors:  Patricia Freis; Julien Bollard; Justine Lebeau; Patrick Massoma; Joëlle Fauvre; Cécile Vercherat; Thomas Walter; Serge Manié; Colette Roche; Jean-Yves Scoazec; Carole Ferraro-Peyret
Journal:  Oncotarget       Date:  2017-03-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.